Melissa Langjahr1, Anna-Lena Schubert1, Claudia Sommer1, Nurcan Üçeyler2. 1. Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany. 2. Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany. ueceyler_n@ukw.de.
Abstract
BACKGROUND: Distinct cytokine expression patterns have been reported in biomaterial of patients with polyneuropathies (PNP). We investigated gene expression profiles of pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells (PBMC) of patients with neuropathies of different etiologies. METHODS: We prospectively studied 97 patients with neuropathies and compared data between diagnostic subgroups and healthy controls. Gene expression of a panel of pro- and anti-inflammatory cytokines was analyzed (interleukin-1 [IL-1], IL-2, IL-6, IL-8, tumor necrosis factor alpha [TNF], IL-4, and IL-10) in PBMC samples. Furthermore, protein levels of IL-6, IL-8, and TNF were measured in supernatant of PBMC stimulated with lipopolysaccharide (LPS). RESULTS: PNP were associated with higher PBMC gene expression of IL-1 (p < 0.05), IL-2 (p < 0.05), IL-8 (p < 0.001), and TNF (p < 0.01) compared to healthy controls. Inflammatory neuropathies were associated with higher gene expression of IL-8 (p < 0.001) and TNF (p < 0.05) and lower gene expression of IL-10 (p < 0.05) compared to healthy controls. More pro-inflammatory cytokines were elevated in painful neuropathy (IL-1, IL-2 [p < 0.05], IL-8 [p < 0.001] and TNF [p < 0.05]) than in painless neuropathy (IL-8 [p < 0.01] and TNF [p < 0.01]) compared to healthy controls, while IL-10 expression was higher in treatment naïve patients with painless neuropathy compared to patients with painful neuropathy (p < 0.05). Disease duration positively correlated with IL-6 gene expression (p < 0.01). Supernatant protein levels of IL-6, IL-8, and TNF did not differ between groups. CONCLUSION: Systemic gene expression of pro-inflammatory cytokines is increased in patients with neuropathies and may be influenced by the presence of neuropathic pain.
BACKGROUND: Distinct cytokine expression patterns have been reported in biomaterial of patients with polyneuropathies (PNP). We investigated gene expression profiles of pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells (PBMC) of patients with neuropathies of different etiologies. METHODS: We prospectively studied 97 patients with neuropathies and compared data between diagnostic subgroups and healthy controls. Gene expression of a panel of pro- and anti-inflammatory cytokines was analyzed (interleukin-1 [IL-1], IL-2, IL-6, IL-8, tumor necrosis factor alpha [TNF], IL-4, and IL-10) in PBMC samples. Furthermore, protein levels of IL-6, IL-8, and TNF were measured in supernatant of PBMC stimulated with lipopolysaccharide (LPS). RESULTS: PNP were associated with higher PBMC gene expression of IL-1 (p < 0.05), IL-2 (p < 0.05), IL-8 (p < 0.001), and TNF (p < 0.01) compared to healthy controls. Inflammatory neuropathies were associated with higher gene expression of IL-8 (p < 0.001) and TNF (p < 0.05) and lower gene expression of IL-10 (p < 0.05) compared to healthy controls. More pro-inflammatory cytokines were elevated in painful neuropathy (IL-1, IL-2 [p < 0.05], IL-8 [p < 0.001] and TNF [p < 0.05]) than in painless neuropathy (IL-8 [p < 0.01] and TNF [p < 0.01]) compared to healthy controls, while IL-10 expression was higher in treatment naïve patients with painless neuropathy compared to patients with painful neuropathy (p < 0.05). Disease duration positively correlated with IL-6 gene expression (p < 0.01). Supernatant protein levels of IL-6, IL-8, and TNF did not differ between groups. CONCLUSION: Systemic gene expression of pro-inflammatory cytokines is increased in patients with neuropathies and may be influenced by the presence of neuropathic pain.
Authors: Susanne Renaud; Arthur P Hays; Thomas H Brannagan; Howard W Sander; Mark Edgar; Louis H Weimer; Marcelo R Olarte; Marinos C Dalakas; Zhaoying Xiang; Moris J Danon; Norman Latov Journal: J Neuroimmunol Date: 2004-12-19 Impact factor: 3.478
Authors: Benjamin Luchting; Banafscheh Rachinger-Adam; Jens Heyn; Ludwig Christian Hinske; Simone Kreth; Shahnaz Christina Azad Journal: J Neuroinflammation Date: 2015-01-21 Impact factor: 8.322
Authors: Emmanuel Bäckryd; Andreas Themistocleous; Anders Larsson; Torsten Gordh; Andrew S C Rice; Solomon Tesfaye; David L Bennett; Björn Gerdle Journal: Pain Date: 2022-05-01 Impact factor: 6.961
Authors: Kord M Kober; Mark Schumacher; Yvette P Conley; Kimberly Topp; Melissa Mazor; Marilynn J Hammer; Steven M Paul; Jon D Levine; Christine Miaskowski Journal: Mol Pain Date: 2019 Jan-Dec Impact factor: 3.395
Authors: Christine Miaskowski; Kimberly Topp; Yvette P Conley; Steven M Paul; Michelle Melisko; Mark Schumacher; Margaret Chesney; Gary Abrams; Jon D Levine; Kord M Kober Journal: J Neuroimmunol Date: 2019-08-02 Impact factor: 3.478
Authors: Vesna Gorenjak; Dwaine R Vance; Alexandros M Petrelis; Maria G Stathopoulou; Sébastien Dadé; Said El Shamieh; Helena Murray; Christine Masson; John Lamont; Peter Fitzgerald; Sophie Visvikis-Siest Journal: PLoS One Date: 2019-08-16 Impact factor: 3.240